Drugs Made In America Acquisition Corp. Rights

DMAAR · NASDAQ

0.125USD+0.02 (+17.59%)

Price History

Full chart

Market Stats

Previous Close0.1063

Open0.1275

Day Range0.1125 – 0.1275

52-Week Range0.04 – 0.2395

Volume400

Market Cap1.83M

P/E (TTM)0.00

Forward P/E0.00

Dividend Yield0.00%

50-Day Avg0.00

200-Day Avg0.00

About

Drugs Made In America Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combinations with one or more businesses. Drugs Made In America Acquisition Corp. was incorporated in 2024 and is based in New York, New York.

Company Details

CEOMr. Roger Bendelac
Employees0
Headquarters420 Lexington Avenue, New York, NY, United States, 10170, USA
Websitehttps://dmaacorp.com

Leadership

Mr. Roger BendelacChief Executive Officer · b. 1957

Key Statistics & Ratios

Market Cap1.83M

Enterprise Value0

Trailing P/E0.00

Forward P/E0.00

Price / Sales0.00

Price / Book0.00

Book Value-0.305

Revenue (TTM)0

Gross Profit (TTM)0

Profit Margin0.00%

Operating Margin0.00%

Return on Equity0.00%

Return on Assets-1.46%

Shares Outstanding20.40M

Shares Float19.69M

Dividend Yield0.00%

Dividend Rate0.00

Payout Ratio0.00%